TSX up after index logs fresh record high close
American Well Corp (AMWL) Chief Accounting Officer McNeice Paul Francis reported selling 113 shares of Class A Common Stock on September 2, 2025. The shares were sold at a price of $6.7815, for a total value of $766. The telehealth company, currently valued at $107 million, has seen its stock decline by 23% over the past six months, though InvestingPro analysis suggests the stock is trading below its Fair Value.
Following the transaction, McNeice Paul Francis directly owns 3892 shares of the company. According to InvestingPro data, AMWL maintains a strong balance sheet with more cash than debt and a healthy current ratio of 3.29, indicating solid short-term liquidity. Discover more insights with InvestingPro’s comprehensive research report, available along with 7 additional key ProTips for AMWL.
The sales reported were made to cover the tax liability arising from the vesting and settlement of restricted stock units on September 1, 2025. The sales were effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
In other recent news, Amwell reported a significant increase in revenue for the second quarter of 2025, totaling $70.9 million, which marks a 13% rise compared to the same period last year. This growth is attributed to the company’s strategic initiatives in artificial intelligence and digital healthcare solutions. Meanwhile, Wells Fargo revised its long-term revenue projections for Amwell and subsequently lowered the stock’s price target from $15 to $12, while maintaining an Overweight rating. The adjustment is based on Wells Fargo’s discounted cash flow model. These developments highlight the evolving landscape for Amwell as it continues to focus on enhancing its digital healthcare offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.